MBNL-dependent impaired development within the neuromuscular system in Myotonic Dystrophy type 1.
Julie Tahraoui-BoriesAntoine MérienAnchel Gonzàlez-BarrigaJeanne LainéCéline LeteurHélène PolvècheAlexandre CarteronJuliette Duchesne De LamotteCamille NicoleauJérome PolentesMargot JarrigeMàrio Gomes-PereiraErwann VentrePauline PoydenotDenis FurlingLaurent SchaefferClaire LegayCécile MartinatPublished in: Neuropathology and applied neurobiology (2022)
Beyond the application to DM1, our approach to generating a robust and reliable human neuromuscular system should facilitate disease modelling studies and drug screening assays.